Infarct Size Reduction With Cyclosporine A in Circulatory Death Rat Hearts: Reducing Effective Ischemia Time With Therapy During Reperfusion
- PMID: 39301719
- PMCID: PMC11479819
- DOI: 10.1161/CIRCHEARTFAILURE.124.011846
Infarct Size Reduction With Cyclosporine A in Circulatory Death Rat Hearts: Reducing Effective Ischemia Time With Therapy During Reperfusion
Keywords: calcium; cyclosporine; mitochondrial permeability transition pore; reperfusion injury; warm ischemia.
Conflict of interest statement
None.
Figures
References
-
- Schroder JN, Patel CB, DeVore AD, Bryner BS, Casalinova S, Shah A, Smith JW, Fiedler AG, Daneshmand M, Silvestry S et al. Transplantation Outcomes with Donor Hearts after Circulatory Death. N Engl J Med. 2023;388:2121–2131. - PubMed
-
- Quader M, Akande O, Cholyway R, Lesnefsky EJ, Toldo S, Chen Q. Infarct Size With Incremental Global Myocardial Ischemia Times: Cyclosporine A in Donation After Circulatory Death Rat Hearts. Transplant Proc. 2023;55:1495–1503. - PubMed
-
- Yellon DM & Hausenloy DJ Myocardial Reperfusion Injury. N Engl J Med. 2007;357:1121–1135. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
